GlassScriptPhysician profile
Bridget C Brodecky
NPI 1871913392
$855.63
in general payments reported to CMS, 2019-2025
17 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $363 · 2023: $170 · 2024: $91.24 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $166.20 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.88 | 2023 | |
| Incyte Corporation | $99.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $77.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $59.86 | 2025 | Rexulti |
| Janssen Scientific Affairs, LLC | $50.90 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.40 | 2025 | |
| Adaptive Biotechnologies Corporation | $32.13 | 2022-2023 | Clonoseq |
| Abbvie INC. | $24.42 | 2025 | |
| Genzyme Corporation | $23.65 | 2021 | |
| Boston Scientific Corporation | $22.59 | 2024 | Versacross Steerable Access Solution |
| Janssen Biotech, INC. | $21.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.33 | 2022 | |
| Pfizer INC. | $17.75 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.71 | 2023 | Enhertu |
| Astellas Pharma US INC | $15.24 | 2023 | Xospata |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Brodecky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.